← SynDRA
ISBUFYLLINE
SynDRA canonical compound SYN0025331 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APEX1
- CBX1
- GMNN
- HDAC6
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Isbufilina
- TE/06
- Isbufyllinum
- 1,3-dimethyl-7-isobutylxanthine
- 9C8Z5F38D0
- TE-06
- DTXCID4026767
- isbufillina
- RefChem:148921
- Isbufylline [INN]
- 7-Isobutyltheophylline
- Isbufilina [INN-Spanish]
- Isbufyllinum [INN-Latin]
- Theophylline, 7-isobutyl-
- 1,3-Dimethyl-7-isobutyl-xanthine
- 1,3-dimethyl-7-(2-methylpropyl)purine-2,6-dione
- UNII-9C8Z5F38D0
- NCGC00168348-01
- SMR000387044
- CAS-90162-60-0
- 7-Isobutyl-1,3-dimethylxanthine
- Theophylline;
- N -(2-Methylpropyl);
- Te06
- Cambridge id 6254600
- Oprea1_221483
- Oprea1_385138
- MLS001049024
- MLS001240237
- SCHEMBL678978
- orb1297861
- WHUWQSQEVISUMC-UHFFFAOYSA-N
- HMS2236M03
- HMS3369C19
- Tox21 112621
- Tox21_112621
- EBC-50067
- AKOS001296693
Look up ISBUFYLLINE in the interactive SynDRA portal →